Telehealth Weight Loss
Iowa

During your telehealth consultation, our healthcare provider will evaluate your medical history, weight loss goals, and overall health. Semaglutide and Tirzepatide are typically recommended for individuals with a BMI of 30 or higher or those with a BMI of 27 or higher who have weight-related health conditions like type 2 diabetes or hypertension. Based on this assessment, we will determine if one of these medications is an appropriate choice for you.

The dosage of Semaglutide or Tirzepatide varies from person to person, depending on factors like your starting weight, health conditions, and how your body responds to the medication. During the consultation, our healthcare provider will determine the right starting dose for you, and we may gradually adjust it as you progress. This titration approach helps to minimize side effects and ensures the medication works effectively to help you achieve your goals.

While individual results may vary, many people start to notice weight loss within the first few weeks of starting treatment. Significant weight loss typically occurs over several months, with the most substantial results often visible by the 12-week mark. Semaglutide can help you lose up to 15% of your initial body weight in a few months, and Tirzepatide can help you lose up to 20% of your initial body weight in the same period.

Like any medication, Semaglutide and Tirzepatide can have side effects, although not everyone experiences them. The most common side effects include nausea, diarrhea, vomiting, and constipation, particularly when starting the medication or increasing the dosage. These side effects are usually temporary and subside as your body adjusts.

The length of time you’ll need to take Semaglutide or Tirzepatide depends on your individual weight loss goals and how your body responds to the medication. Many people take these medications long-term to maintain their weight loss and continue experiencing the benefits.